Results 41 to 50 of about 2,733 (199)

Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis

open access: yesFrontiers in Pharmacology, 2023
Mpox (earlier known as monkeypox) virus infection is a recognized public health emergency. There has been little research on the treatment options. This article reviews the specific drugs used to treat mpox virus infection and the vaccines used here ...
Muhammad Aaqib Shamim   +21 more
doaj   +1 more source

Removing Barriers to Tecovirimat for Mpox-infected Individuals via Novel Models of Care Delivery [PDF]

open access: yes, 2023
Problem Statement During the 2022 mpox outbreak, the CDC’s expanded access Investigational New Drug (IND) protocol created a practical barrier to the outpatient provision of tecovirimat.
Coppock, MD. MSCE, Dagan   +4 more
core   +1 more source

Monkeypox: a global health emergency

open access: yesFrontiers in Microbiology, 2023
Over the past 2 years, the world has faced the impactful Coronavirus Disease-2019 (COVID-19) pandemic, with a visible shift in economy, medicine, and beyond.
Ruxandra Ilinca Stilpeanu   +9 more
doaj   +1 more source

Antivirals against Monkeypox (Mpox) in Humans: An Updated Narrative Review

open access: yesLife, 2023
As of 29 August 2023, a total of 89,596 confirmed cases of Mpox (monkeypox) have been documented across 114 countries worldwide, with 157 reported fatalities.
Giuseppe Bruno   +1 more
doaj   +1 more source

Acute respiratory distress syndrome due to monkeypox virus

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2023
We report the first case of monkeypox virus (MPXV) associated acute respiratory distress syndrome (ARDS). A 34-year-old French woman with no medical history was admitted to the intensive care unit (ICU) for fever, altered mental status, hypotension and ...
Tona Tchoubou   +6 more
doaj   +1 more source

VP37 Protein Inhibitors for Mpox Treatment: Highlights on Recent Advances, Patent Literature, and Future Directions

open access: yesBiomedicines, 2023
Monkeypox disease (Mpox) has threatened humankind worldwide since mid-2022. The Mpox virus (MpoxV) is an example of Orthopoxviruses (OPVs), which share similar genomic structures. A few treatments and vaccines are available for Mpox.
Shuaibu A. Hudu   +3 more
doaj   +1 more source

Comprehensive update on the monkeypox outbreak

open access: yesFrontiers in Microbiology, 2022
Monkeypox (MPX) was first reported in 1970 in humans and outbreaks were restricted and highly localised to endemic regions of western and central Africa.
Asad Mustafa Karim   +7 more
doaj   +1 more source

Development and Validation of a Method of Liquid Chromatography Coupled with Tandem Mass Spectrometry for Quantification of ST-246 (Tecovirimat) in Human Plasma

open access: yesMolecules, 2022
The aim of this work was to develop and validate a sensitive and robust method of liquid chromatography coupled with tandem mass spectrometry to quantitate ST-246 (tecovirimat) in plasma using an internal standard (2-hydroxy-N-{3,5-dioxo-4-azatetracyclo [
Galina A. Oleinik   +4 more
doaj   +1 more source

A REVIEW OF MONKEYPOX DISEASE AND FUTURE TREATMENT OPTIONS [PDF]

open access: yes, 2023
The Monkeypox virus (MPXV) causative agent for Monkeypox disease resembles a smallpox-like illness and can lead to a number of serious medical issues in humans.
MISRA, SAURAV, SHUKLA, AJAY KUMAR
core   +1 more source

Case report: From monkeypox pharyngitis to myopericarditis and atypical skin lesions

open access: yesFrontiers in Cardiovascular Medicine, 2023
BackgroundA global outbreak of the human monkeypox virus (HMPXV), first identified in May 2022, was declared a health emergency of international concern on 23 July 2022. Before the global outbreak, monkeypox cases were mostly confined to central and west
María Ascensión Sanromán Guerrero   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy